These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
358 related articles for article (PubMed ID: 29084737)
1. Frequency, Predictors, and Impact of Combined Antiplatelet Therapy on Venous Thromboembolism in Patients With Symptomatic Atherosclerosis. Cavallari I; Morrow DA; Creager MA; Olin J; Bhatt DL; Steg PG; Storey RF; Cohen M; Scirica BS; Piazza G; Goodrich EL; Braunwald E; Sabatine MS; Bonaca MP Circulation; 2018 Feb; 137(7):684-692. PubMed ID: 29084737 [TBL] [Abstract][Full Text] [Related]
2. Prevention of Stroke with Ticagrelor in Patients with Prior Myocardial Infarction: Insights from PEGASUS-TIMI 54 (Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin-Thrombolysis in Myocardial Infarction 54). Bonaca MP; Goto S; Bhatt DL; Steg PG; Storey RF; Cohen M; Goodrich E; Mauri L; Ophuis TO; Ruda M; Špinar J; Seung KB; Hu D; Dalby AJ; Jensen E; Held P; Morrow DA; Braunwald E; Sabatine MS Circulation; 2016 Sep; 134(12):861-71. PubMed ID: 27576775 [TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety with ticagrelor in patients with prior myocardial infarction in the approved European label: insights from PEGASUS-TIMI 54. Dellborg M; Bonaca MP; Storey RF; Steg PG; Im KA; Cohen M; Bhatt DL; Oude Ophuis T; Budaj A; Hamm C; Spinar J; Kiss RG; Lopez-Sendon J; Kamensky G; Van de Werf F; Ardissino D; Kontny F; Montalescot G; Johanson P; Bengtsson O; Himmelmann A; Braunwald E; Sabatine MS Eur Heart J Cardiovasc Pharmacother; 2019 Oct; 5(4):200-206. PubMed ID: 31218354 [TBL] [Abstract][Full Text] [Related]
4. Predictors, Type, and Impact of Bleeding on the Net Clinical Benefit of Long-Term Ticagrelor in Stable Patients With Prior Myocardial Infarction. Magnani G; Ardissino D; Im K; Budaj A; Storey RF; Steg PG; Bhatt DL; Cohen M; Oude Ophius T; Goudev A; Parkhomenko A; Kamensky G; Angiolillo DJ; López-Sendón J; Johanson P; Braunwald E; Sabatine MS; Bonaca MP J Am Heart Assoc; 2021 Feb; 10(4):e017008. PubMed ID: 33559485 [TBL] [Abstract][Full Text] [Related]
5. Ticagrelor for Prevention of Ischemic Events After Myocardial Infarction in Patients With Peripheral Artery Disease. Bonaca MP; Bhatt DL; Storey RF; Steg PG; Cohen M; Kuder J; Goodrich E; Nicolau JC; Parkhomenko A; López-Sendón J; Dellborg M; Dalby A; Špinar J; Aylward P; Corbalán R; Abola MTB; Jensen EC; Held P; Braunwald E; Sabatine MS J Am Coll Cardiol; 2016 Jun; 67(23):2719-2728. PubMed ID: 27046162 [TBL] [Abstract][Full Text] [Related]
7. Reduction in Ischemic Events With Ticagrelor in Diabetic Patients With Prior Myocardial Infarction in PEGASUS-TIMI 54. Bhatt DL; Bonaca MP; Bansilal S; Angiolillo DJ; Cohen M; Storey RF; Im K; Murphy SA; Held P; Braunwald E; Sabatine MS; Steg PG J Am Coll Cardiol; 2016 Jun; 67(23):2732-2740. PubMed ID: 27046160 [TBL] [Abstract][Full Text] [Related]
8. Acute Limb Ischemia and Outcomes With Vorapaxar in Patients With Peripheral Artery Disease: Results From the Trial to Assess the Effects of Vorapaxar in Preventing Heart Attack and Stroke in Patients With Atherosclerosis-Thrombolysis in Myocardial Infarction 50 (TRA2°P-TIMI 50). Bonaca MP; Gutierrez JA; Creager MA; Scirica BM; Olin J; Murphy SA; Braunwald E; Morrow DA Circulation; 2016 Mar; 133(10):997-1005. PubMed ID: 26826179 [TBL] [Abstract][Full Text] [Related]
9. Long-term use of ticagrelor in patients with prior myocardial infarction. Bonaca MP; Bhatt DL; Cohen M; Steg PG; Storey RF; Jensen EC; Magnani G; Bansilal S; Fish MP; Im K; Bengtsson O; Oude Ophuis T; Budaj A; Theroux P; Ruda M; Hamm C; Goto S; Spinar J; Nicolau JC; Kiss RG; Murphy SA; Wiviott SD; Held P; Braunwald E; Sabatine MS; N Engl J Med; 2015 May; 372(19):1791-800. PubMed ID: 25773268 [TBL] [Abstract][Full Text] [Related]
10. Atherothrombotic Risk Stratification and the Efficacy and Safety of Vorapaxar in Patients With Stable Ischemic Heart Disease and Previous Myocardial Infarction. Bohula EA; Bonaca MP; Braunwald E; Aylward PE; Corbalan R; De Ferrari GM; He P; Lewis BS; Merlini PA; Murphy SA; Sabatine MS; Scirica BM; Morrow DA Circulation; 2016 Jul; 134(4):304-13. PubMed ID: 27440003 [TBL] [Abstract][Full Text] [Related]
11. Time to Loading Dose and Risk of Recurrent Events in the SOCRATES Trial. Molina CA; Johnston SC; Ladenvall P; Amarenco P; Albers GW; Denison H; Easton JD; Evans SR; Held P; Knutsson M; Minematsu K; Röther J; Wang Y; Wong KSL; Stroke; 2019 Mar; 50(3):675-682. PubMed ID: 30776996 [TBL] [Abstract][Full Text] [Related]
12. Design and rationale for the Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin-Thrombolysis in Myocardial Infarction 54 (PEGASUS-TIMI 54) trial. Bonaca MP; Bhatt DL; Braunwald E; Cohen M; Steg PG; Storey RF; Held P; Jensen EC; Sabatine MS Am Heart J; 2014 Apr; 167(4):437-444.e5. PubMed ID: 24655690 [TBL] [Abstract][Full Text] [Related]
13. Gut Microbiota-Dependent Trimethylamine N-oxide and Cardiovascular Outcomes in Patients With Prior Myocardial Infarction: A Nested Case Control Study From the PEGASUS-TIMI 54 Trial. Gencer B; Li XS; Gurmu Y; Bonaca MP; Morrow DA; Cohen M; Bhatt DL; Steg PG; Storey RF; Johanson P; Wang Z; Hazen SL; Sabatine MS J Am Heart Assoc; 2020 May; 9(10):e015331. PubMed ID: 32366163 [TBL] [Abstract][Full Text] [Related]
14. Ticagrelor for Secondary Prevention of Atherothrombotic Events in Patients With Multivessel Coronary Disease. Bansilal S; Bonaca MP; Cornel JH; Storey RF; Bhatt DL; Steg PG; Im K; Murphy SA; Angiolillo DJ; Kiss RG; Parkhomenko AN; Lopez-Sendon J; Isaza D; Goudev A; Kontny F; Held P; Jensen EC; Braunwald E; Sabatine MS; Oude Ophuis AJ J Am Coll Cardiol; 2018 Feb; 71(5):489-496. PubMed ID: 29406853 [TBL] [Abstract][Full Text] [Related]
15. Caffeinated Beverage Intake, Dyspnea With Ticagrelor, and Cardiovascular Outcomes: Insights From the PEGASUS-TIMI 54 Trial. Furtado RHM; Venkateswaran RV; Nicolau JC; Gurmu Y; Bhatt DL; Storey RF; Steg PG; Magnani G; Goto S; Dellborg M; Kamensky G; Isaza D; Aylward P; Johanson P; Bonaca MP J Am Heart Assoc; 2020 May; 9(10):e015785. PubMed ID: 32410485 [TBL] [Abstract][Full Text] [Related]
16. Vorapaxar in patients with diabetes mellitus and previous myocardial infarction: findings from the thrombin receptor antagonist in secondary prevention of atherothrombotic ischemic events-TIMI 50 trial. Cavender MA; Scirica BM; Bonaca MP; Angiolillo DJ; Dalby AJ; Dellborg M; Morais J; Murphy SA; Ophuis TO; Tendera M; Braunwald E; Morrow DA Circulation; 2015 Mar; 131(12):1047-53. PubMed ID: 25681464 [TBL] [Abstract][Full Text] [Related]
17. The Acute S Johnston SC; Amarenco P; Denison H; Evans SR; Himmelmann A; James S; Knutsson M; Ladenvall P; Molina CA; Wang Y; Int J Stroke; 2019 Oct; 14(7):745-751. PubMed ID: 30747613 [TBL] [Abstract][Full Text] [Related]
18. Cost-Effectiveness of Long-Term Ticagrelor in Patients With Prior Myocardial Infarction: Results From the PEGASUS-TIMI 54 Trial. Magnuson EA; Li H; Wang K; Vilain K; Shafiq A; Bonaca MP; Bhatt DL; Cohen M; Steg PG; Storey RF; Braunwald E; Sabatine MS; Cohen DJ; J Am Coll Cardiol; 2017 Aug; 70(5):527-538. PubMed ID: 28750695 [TBL] [Abstract][Full Text] [Related]
19. Long-term ticagrelor for secondary prevention in patients with prior myocardial infarction and no history of coronary stenting: insights from PEGASUS-TIMI 54. Furtado RHM; Nicolau JC; Magnani G; Im K; Bhatt DL; Storey RF; Steg PG; Spinar J; Budaj A; Kontny F; Corbalan R; Kiss RG; Abola MT; Johanson P; Jensen EC; Braunwald E; Sabatine MS; Bonaca MP Eur Heart J; 2020 May; 41(17):1625-1632. PubMed ID: 31811715 [TBL] [Abstract][Full Text] [Related]
20. Dose-related effect of statins in venous thrombosis risk reduction. Khemasuwan D; Chae YK; Gupta S; Carpio A; Yun JH; Neagu S; Lucca AB; Valsecchi ME; Mora JI Am J Med; 2011 Sep; 124(9):852-9. PubMed ID: 21783169 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]